Available data no longer supports a probable late mortality risk associated with paclitaxel-coated devices used to treat femoropopliteal disease.

http://www.fda.gov/medical-devices/letters-health-care-providers/update-paclitaxel-coated-devices-treat-peripheral-arterial-disease-unlikely-increase-risk-mortality